These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7000718)

  • 21. Plasma renin in hypertensive patients: significance in relation to clinical and other biochemical features.
    Russell GI; Bing RF; Thurston H; Swales JD
    Q J Med; 1980; 49(195):385-94. PubMed ID: 7008072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma renin activity in arterial hypertension].
    Woźniak K; Janicka L; Szczepański L; Tomaszewski J
    Ann Univ Mariae Curie Sklodowska Med; 1969; 24():143-52. PubMed ID: 5406024
    [No Abstract]   [Full Text] [Related]  

  • 24. The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure.
    Jablecka A; Chmara E; Korzeniowska K
    Int J Clin Pharmacol Res; 1998; 18(4):171-8. PubMed ID: 10052027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canrenoate reversal of inhibitory effects of digoxin on basal and furosemide-stimulated renin secretion.
    Finotti P; Antonello A
    Clin Pharmacol Ther; 1982 Jul; 32(1):1-6. PubMed ID: 6282524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of oxprenolol on the plasma renin activity in essential arterial hypertension].
    Cospite M; Lo Presti T; Ferrara F; Mineo R
    Boll Soc Ital Cardiol; 1977; 22(3):335-9. PubMed ID: 617279
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
    Nussberger J; Gradman AH; Schmieder RE; Lins RL; Chiang Y; Prescott MF
    Int J Clin Pract; 2007 Sep; 61(9):1461-8. PubMed ID: 17590217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glycoside therapy in elderly patients (author's transl)].
    Haasis R
    Aktuelle Gerontol; 1980 Oct; 10(10):435-8. PubMed ID: 6110348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma digoxin-like substance in hypertensive patients].
    Fortina F; Agliata S; Cavagnino A; Sbaffi A; Airoldi G; Ragazzoni E
    Minerva Urol Nefrol; 1988; 40(3):211-4. PubMed ID: 3070797
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of prostaglandin inhibition on renin release. A comparison of furosemide and low-sodium stimulation tests.
    Goldiner WH; Valente WA; Hamilton BP; Mersey JH
    J Lab Clin Med; 1981 Dec; 98(6):929-37. PubMed ID: 7031155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
    Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of renin-angiotensin system activation by dietary sodium restriction and upright position on plasma leptin concentration in patients with essential hypertension.
    Adamczak M; Kokot F; Chudek J; Wiecek A
    Med Sci Monit; 2002 Jul; 8(7):CR473-7. PubMed ID: 12118193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers].
    Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M
    Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin responsiveness to furosemide in the homotransplanted kidney.
    Lebel M; Lachance JG; Grose JH
    Biomedicine; 1981 Jul; 35(3):81-4. PubMed ID: 7023561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
    Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
    Ignatowska-Switalska H; Wocial B; Skórka B; Chodakowska J; Nazar K; Chwalbińska-Moneta J
    Acta Physiol Pol; 1980; 31(6):631-5. PubMed ID: 7018172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.